Blood-based screening for CRC may be better than no screening at all, but it can't replace colonoscopy as the gold standard, according to two new modeling studies and an expert consensus commentary.
In unscreened adults who refuse colonoscopy, liquid biopsy tests may not have sufficient performance and cost too much to be a viable strategy at this time, an economic analysis suggests.